Skip to content

Janus Living JAN Lease Liability Payments - Due Year Four

Lease Liability Payments - Due Year Four at other companies

Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$4.7M-2.8%
Gross profit$3.6M+85.6%
Operating income-$2.7M-41.0%
Net income-$271.5M-11,250%
EPS (diluted)-$2.14-1,327%

Balance sheet

See full
Cash & equivalents$10.5M-2.7%
Total debt$107.0K-99.4%
Total equity$889.7M+3,976%
Total assets$959.7M+1,130%

Cash flow

See full
Operating cash flow-$12.3M-764%
CapEx$2.8K
Free cash flow-$1.8M

Valuation

See full
Market cap$5.56B+43,568%
Enterprise value$5.55B+26,232%
P/S231.5×+231×

Profitability

See full
Gross margin46.5%+1.2pp
Operating margin-99.7%-717pp
Net margin-2,552.7%-2,601pp
FCF margin-29.7%

Returns & leverage

See full
Return on equity-134.6%-791pp
Debt / equity-0.5×
Current ratio0.8×0.0×

Where this comes from

Reported directly by Janus Living in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour.

The official record: Janus Living ’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janus Living 's lease liability payments - due year four.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Janus Living 's lease liability payments - due year four?
Janus Living (JAN) reported lease liability payments - due year four of $26K in Q2 2026.
How has Janus Living 's lease liability payments - due year four changed year-over-year?
Janus Living 's lease liability payments - due year four decreased by 31.6% year-over-year, from $38K to $26K.
What does lease liability payments - due year four mean?
The contractual cash obligations for operating and finance leases due in the fourth year following the balance sheet date. This is part of the long-term lease maturity schedule that helps investors assess the company's future fixed cost burden. It allows for better modeling of long-term capital allocation and cash flow stability.